The 37 references in paper A. Stukan' I., O. Chukhray Yu., V. Porkhanov A., R. Murashko A., V. Bodnya N., Yu. Makarova M., А. Стукань И., О. Чухрай Ю., В. Порханов А., Р. Мурашко А., В. Бодня H., Ю. Макарова М. (2018) “Орофарингеальная карцинома, ассоциированная с вирусом папилломы человека: тенденции эпидемиологии и методы выявления вируса в опухоли // Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors” / spz:neicon:ogsh:y:2018:i:3:p:77-83

1
Kofler B., Laban S., Busch C. J. et al. New treatment strategies for HPV-positive head and neck cancer. Eur Arch Otorhinolaryngol 2014;271(7):1861–7. DOI: 10.1007/s00405-013-2603-0. PMID: 23934317.
(check this in PDF content)
2
Smith E. M., Ritchie J. M., Summersgill K. F. et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004;108(5):766–72. DOI: 10.1002/ ijc.11633. PMID: 14696105.
(check this in PDF content)
3
Chaturvedi A. K., Engels E. A., Anderson W. F., Gillison M. L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26(4):612–9. DOI: 10.1200/jco.2007.14.1713. PMID: 18235120.
(check this in PDF content)
4
Mehta V., Yu G. P., Schantz S. P. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope 2010;120(11):2203–12. DOI: 10.1002/lary.21129. PMID: 20938956.
(check this in PDF content)
5
Brown L. M., Check D. P., Devesa S. S. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol 2012;2012:649498. DOI: 10.1155/2012/649498. PMID: 22577381.
(check this in PDF content)
6
Hong A. M., Martin A., Chatfield M. et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int J Cancer 2013;132(12): 2748–54. DOI: 10.1002/ijc.27956. PMID: 23180456.
(check this in PDF content)
7
Gillison M. L., D’Souza G., Westra W. et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100(6):407–20. DOI: 10.1093/jnci/djn025. PMID: 18334711.
(check this in PDF content)
8
Bajos N., Bozon M., Beltzer N. et al. Changes in sexual behaviours: from secular trends to public health policies. AIDS 2010;24(8):1185–91. DOI: 10.1097/qad. 0b013e328336ad52. PMID: 20299962.
(check this in PDF content)
9
D’Souza G., Agrawal Y., Halpern J. et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009;199(9):1263–9. DOI: 10.1086/597755. PMID: 19320589.
(check this in PDF content)
10
Heck J. E., Berthiller J., Vaccarella S. et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010; 39(1):166–81. DOI: 10.1093/ije/dyp350. PMID: 20022926.
(check this in PDF content)
11
Dahlstrom K. R., Li G., TortoleroLuna G. et al. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 2011;33(6):847–55. DOI: 10.1002/hed.21550. PMID: 20737488.
(check this in PDF content)
12
Herrero R., Castellsagué X., Pawlita M. et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95(23):1772–83. DOI: 10.1093/jnci/djg107. PMID: 14652239.
(check this in PDF content)
13
D’Souza G., Kreimer A. R., Viscidi R. et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356(19):1944–56. DOI: 10.1056/nejmoa065497. PMID: 17494927.
(check this in PDF content)
14
D’Souza G., Zhang H. H., D’Souza W. D. et al. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol 2010;46(2):100–4. DOI: 10.1016/j.oraloncology.2009.11.004. PMID: 20036610.
(check this in PDF content)
15
Chaturvedi A. K., Engels E. A., Pfeiffer R. M. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29(32):4294–301. DOI: 10.1200/jco.2011.36.4596. PMID: 21969503.
(check this in PDF content)
16
Hong A. M., Grulich A. E., Jones D. et al. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010;28(19):3269–72. DOI: 10.1016/j.vaccine.2010.02.098. PMID: 20226244.
(check this in PDF content)
17
Dahlstrom K. R., Calzada G., Hanby J. D. et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer 2013;119(1):81–9. DOI: 10.1002/cncr. 27727. PMID: 22736261.
(check this in PDF content)
18
Rainsbury J. W., Ahmed W., Williams H. K. et al. Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and metaanalysis. Head Neck 2013;35(7):1048–55. DOI: 10.1002/hed.22950. PMID: 22997051.
(check this in PDF content)
19
Mammas I. N., Sourvinos G., Zaravinos A., Spandidos D. A. Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers. Pathol Oncol Res 2011;17(1):103–19. DOI: 10.1007/s12253-010-9288-0. PMID: 20640607.
(check this in PDF content)
20
Venuti A., Badaracco G., Rizzo C. et al. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res 2004;23(4):561–6. DOI: 10.3892/or. 17.4.931. PMID: 15743024.
(check this in PDF content)
21
Dahlstrand H., Näsman A., Romanitan M. et al. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008;28(2B):1133–8. DOI: 10.1007/978-90-481-3186-0_19. PMID: 18505048.
(check this in PDF content)
22
Ryerson A. B., Peters E. S., Coughlin S. S. et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer 2008;113(10 Suppl): 2901–9. DOI: 10.1002/cncr.23745. PMID: 18980273.
(check this in PDF content)
23
Li W., Tran N., Lee S. C. et al. New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology 2007;39(2):217–22. DOI: 10.1080/00313020701230823. PMID: 17454751.
(check this in PDF content)
24
Hafkamp H. C., Manni J. J., Haesevoets A. et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008;122(12):2656–64. DOI: 10.1002/ijc.23458. PMID: 18360824.
(check this in PDF content)
25
Nichols A. C., Dhaliwal S. S., Palma D. A. et al. Does HPV type affect outcome in oropharyngeal cancer? J Otolaryngol Head Neck Surg 2013;42:9. DOI: 10.1186/1916-0216-42-9. PMID: 23663293.
(check this in PDF content)
26
Sturgis E. M., Cinciripini P. M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110(7):1429–35. DOI: 10.1002/cncr.22963. PMID: 17724670.
(check this in PDF content)
27
Hariri S., Unger E. R., Sternberg M. et al. Prevalence of genital human papillo mavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003–2006. J Infect Dis 2011;204(4):566–73. DOI: 10.1093/infdis/jir341. PMID: 21791659.
(check this in PDF content)
28
Giuliano A. R., Lazcano-Ponce E., Villa L. L. et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008;17(8): 2036–43. DOI: 10.1158/1055-9965. EPI-08-0151. PMID: 18708396.
(check this in PDF content)
29
Robinson M., Sloan P., Shaw R. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010;46(7):492–6. DOI: 10.1016/j.oraloncology.2010.02.013. PMID: 20227331.
(check this in PDF content)
30
Grønhøj Larsen C., Gyldenløve M., Jensen D. H. et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer 2014; 110(6):1587–94. DOI: 10.1038/ bjc.2014.42. PMID: 24518594.
(check this in PDF content)
31
Boyer S. N., Wazer D. E., Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996;56(20):4620–4. PMID: 8840974.
(check this in PDF content)
32
Schlect N. F., Brandwein-Gensler M., Nuovo G. J. et al. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol 2011;24(10):1295–305. DOI: 10.1038/modpathol.2011.91. PMID: 21572401.
(check this in PDF content)
33
Langendijk J. A., Psyrri A. The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies. Ann Oncol 2010;21(10):1931–4. DOI: 10.1093/annonc/mdq439. PMID: 20716626.
(check this in PDF content)
34
Lewis J. S. Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 2012;6 Suppl 1: S75–82. DOI: 10.1007/ s12105-012-0369-0. PMID: 22782226.
(check this in PDF content)
35
Smeets S. J., Hesselink A. T., Speel E. J. et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121(11):2465–72. DOI: 10.1002/ijc. 22980. PMID: 17680565.
(check this in PDF content)
36
Lewis J. S. Jr, Beadle B., Bishop J. A. et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med 2018;142(5):559–7. DOI: 10.5858/arpa.2017-0286-CP. PMID: 29251996.
(check this in PDF content)
37
Huang S. H., O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 2017;18(7):40. DOI: 10.1007/s11864-017-0484-y.
(check this in PDF content)